Gabelli Health & Wellness (GRX)

Add to Watchlists
Create an Alert
11.30 +0.04  +0.31% NYSE Jul 30, 16:59 Delayed 2m USD
View Full Chart
GRX Price Chart

GRX Description

Gabelli Health & Wellness is a long only equity fund managed by Gabelli that tracks the S&P Health Care Select Sector TR USD index and has 256.06M USD assets under management. It has an forecasted dividend yield of 1.15%, a forecasted PE ratio of 24.45, and a forecasted price to book value of 3.433. The fund has a net expense ratio of 1.36%, turns over its positions 43.50% per year, and is traded on the New York Stock Exchange.

GRX Key Info

Expense Ratio (12-31-14) 1.36%
Assets Under Management (7-30-15) 256.06M
30-Day Average Volume (7-29-15) 39263.37
Net Asset Value (7-30-15) 12.84
Discount or Premium to NAV (7-30-15) -12.07%
Turnover Ratio (12-31-14) 43.50%

GRX Asset Allocation

Type % Net % Long % Short
Cash 7.66% 7.66% 0.00%
Stock 92.33% 92.41% 0.09%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.01% 0.01% 0.00%
As of March 31, 2015

GRX Region Exposure

Americas 86.09%
North America 86.09%
Latin America 0.00%
Greater Europe 9.03%
United Kingdom 1.08%
Europe Developed 7.95%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 4.88%
Japan 4.19%
Australasia 0.00%
Asia Developed 0.23%
Asia Emerging 0.46%
Market Classification
% Developed Markets 99.54%
% Emerging Markets 0.46%
As of March 31, 2015
Region breakdown data is calculated by using the long position holdings of the portfolio.

GRX Stock Sector Exposure

Basic Materials 3.80%
Communication Services 0.00%
Consumer Cyclical 1.68%
Consumer Defensive 34.50%
Energy 0.00%
Financial Services 0.00%
Healthcare 59.18%
Industrials 0.00%
Real Estate 0.17%
Technology 0.67%
Utilities 0.00%
As of March 31, 2015

GRX Stock Market Capitalization

Giant 20.62%
Large 31.10%
Medium 26.10%
Small 6.59%
Micro 7.74%
As of March 31, 2015
View More Holdings

GRX Top 10 Holdings

Symbol Name % Weight Price % Chg
SLXP Salix Pharmaceuticals Ltd 3.26% -- --
-- US Treasury Bill 2.83% -- --
-- US Treasury Bill 2.53% -- --
CVS CVS Health Corp 2.50% 112.97 -0.42%
ACT Actavis PLC 2.47% 328.97 -2.67%
SIAL Sigma-Aldrich Corp 2.09% 139.67 +0.06%
ALR Alere Inc 2.00% 48.61 -1.26%
HSP Hospira Inc 1.79% 89.43 +0.01%
HCA HCA Holdings Inc 1.54% 92.98 -0.62%
2801 Kikkoman Corp 1.50% -- --
As of March 31, 2015
Advertisement

GRX Basic Info

Style
Equity Style Large Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Prospectus Objective Specialty - Health
Fund Owner Firm Name Gabelli
Benchmark Index
S&P Health Care Select Sector TR USD 100.0%

GRX Manager Info

Name Tenure
Jeffrey Jonas 4.79 yrs
Kevin Dreyer 4.79 yrs
Mario Gabelli 7.76 yrs

GRX Risk Info

Beta 0.8409
Max Drawdown (All) 65.00%
Historical Sharpe (10y) --
Historical Sortino (All) 0.8987
30-Day Rolling Volatility 14.39%
Daily Value at Risk (VaR) 1% (All) 4.82%
Monthly Value at Risk (VaR) 1% (All) 17.98%

GRX Fundamentals

Dividend Yield TTM (7-30-15) 5.57%
Weighted Average PE Ratio 25.81
Weighted Average Price to Sales Ratio 1.270
Weighted Average Price to Book Ratio 3.774
Weighted Median ROE 9.75%
Weighted Median ROA 4.67%
Forecasted Dividend Yield 1.15%
Forecasted PE Ratio 24.45
Forecasted Price to Sales Ratio 1.135
Forecasted Price to Book Ratio 3.433
Number of Holdings 143
As of March 31, 2015

GRX Growth Estimates

Forecasted 5 Yr Earnings Growth 10.00%
Forecasted Book Value Growth 4.90%
Forecasted Cash Flow Growth 5.09%
Forecasted Earnings Growth 6.77%
Forecasted Revenue Growth 8.84%
As of March 31, 2015

GRX Performance

  Returns Total Returns
1M 1.03% 1.03%
3M 0.04% 1.23%
6M 6.25% 8.69%
1Y 13.73% 20.70%
3Y 32.69% 76.11%
5Y 80.02% 165.1%
As of July 30, 2015

GRX Net Flows

1M 0.00
3M 0.00
6M 0.00
YTD 0.00
1Y 18.85M
3Y --
5Y --
As of Jan. 31, 2012

GRX Attributes

Key Dates
Inception Date 6/19/2007
Last Annual Report Date 12/31/2014
Last Prospectus Date 12/31/2013
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Index Fund No
Inverse Fund No
Leveraged Fund Yes
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.